MetaVia Inc. (MTVA) États Financiers et Données Historiques

MetaVia Inc. (MTVA) — Prix $1.54 HealthcareBiotechnology — NASDAQ

Derniers résultats publiés:

États financiers détaillés de MetaVia Inc. (MTVA): compte de résultat, bilan et tableau de flux de trésorerie. Suivez l'évolution des marges, de la dette, de la liquidité et de la rentabilité d'une année sur l'autre avec jusqu'à 20 ans d'historique.

Résumé de l'Analyse

Marges des 12 derniers mois: marge brute 0.0%, marge opérationnelle 0.0%, marge nette 0.0%.

Compte de Résultat (10 ans)

Année2016201720182019202020212022202320242025
Revenus0000000000
Coût des Ventes0000$67000$72000$28000$7000$24000$19000
Marge Brute0000-$67000-$72000-$28000-$7000-$24000-$19000
R&D$8.7M$22.7M$13.9M$17.5M$21.9M$6.5M$2.8M$9.2M$21.5M$6.8M
Frais Généraux$6.0M$10.4M$1.6M$2.7M$7.8M$8.8M$8.6M$6.7M$7.3M$6.9M
Charges Opérationnelles$14.7M$33.1M$15.5M$20.2M$29.7M$15.3M$19.6M$15.9M$28.8M$13.7M
Résultat Opérationnel-$14.7M-$33.1M-$15.5M-$20.2M-$29.7M-$15.3M-$19.6M-$15.9M-$28.8M-$13.7M
EBITDA-$14.7M-$33.1M-$15.5M-$20.2M-$29.7M-$15.2M-$11.8M-$12.5M-$27.6M-$13.0M
Charges d'Intérêt0$286000$40000$2200000$2.2M000
Résultat Avant Impôts-$14.6M-$33.4M-$15.5M-$21.3M-$29.7M-$15.3M-$14.0M-$12.5M-$27.6M-$13.0M
Impôts0000000000
Résultat Net-$14.6M-$33.4M-$15.5M-$21.3M-$29.7M-$15.3M-$14.0M-$12.5M-$27.6M-$13.0M
BPA$-106454.37$-213180.00$-112860.00$-10771.20$-4831.20$-1742.40$-477.84$-27.06$-39.16$-7.35
BPA Dilué$-106454.37$-213180.00$-112860.00$-10771.20$-4831.20$-1742.40$-477.84$-27.06$-39.16$-7.35
Actions en Circulation (Diluées)$140$157$209$1979$6143$8767$29246$461009$705193$1.8M

Compte de Résultat (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Revenus0000
Marge Brute0-$5000-$50000
Résultat Opérationnel-$3.5M-$2.0M-$4.0M-$5.4M
EBITDA-$3.4M-$1.9M-$3.8M-$5.4M
Résultat Net-$3.4M-$1.9M-$3.8M-$5.3M
BPA$-1.54$-0.84$-0.79$-0.90
BPA Dilué$-1.54$-0.84$-0.79$-0.90

Bilan (10 ans)

Année2016201720182019202020212022202320242025
Trésorerie$24.0M$18.5M$2.8M$13.9M$10.1M$16.4M$33.4M$22.4M$16.0M$10.3M
Placements à Court Terme0000000000
Créances0000000000
Stocks0000000000
Actifs Courants$24.7M$19.0M$3.8M$14.1M$10.7M$16.6M$33.5M$22.5M$16.1M$10.9M
Immobilisations Corporelles00$12000$350000$285000$215000$2000$248000$167000$227000
Goodwill0000000000
Actifs Incorporels0000000000
Actifs Totaux$24.8M$19.0M$3.8M$14.5M$11.0M$16.8M$33.5M$22.8M$16.3M$69.1M
Dettes Fournisseurs$2.0M$4.0M$170000$638000$2.6M$830000$708000$821000$3.9M$1.1M
Dette à Court Terme0$1.4M$9.4M00$26000000$68000
Passifs Courants$4.1M$6.4M$219000$2.1M$3.7M$2.2M$11.8M$6.0M$8.3M$5.6M
Dette à Long Terme0$8.7M$1180000000000
Passifs Totaux$4.1M$15.1M$17.1M$2.2M$3.8M$2.2M$11.8M$6.1M$8.3M$63.8M
Réserves-$27.1M-$60.5M-$15.6M-$36.9M-$66.5M-$81.8M-$95.8M-$108.3M-$135.9M-$148.8M
Capitaux Propres$20.6M$3.9M-$13.3M$12.3M$7.2M$14.6M$21.8M$16.7M$7.9M$5.3M
Dette Totale0$10.0M$9.6M$116000$94000$710000$203000$136000$210000
Dette Nette-$24.0M-$8.4M$6.7M-$13.8M-$10.0M-$16.3M-$33.4M-$22.2M-$15.9M-$10.1M
Fonds de Roulement$20.6M$12.6M$3.6M$12.0M$7.0M$14.4M$21.7M$16.6M$7.8M$5.2M

Bilan (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Trésorerie$14.3M$10.3M$13.7M$12.6M
Actifs Totaux$14.8M$69.1M$14.4M$13.3M
Passifs Totaux$8.4M$63.8M$5.3M$6.4M
Capitaux Propres$6.3M$5.3M$9.1M$6.8M
Dette Totale$79000$210000$194000$177000

Tableau de Flux (10 ans)

Année2016201720182019202020212022202320242025
Résultat Net-$14.6M-$33.4M-$15.5M-$21.3M-$29.7M-$15.3M-$14.0M-$12.5M-$27.6M-$13.0M
Amortissements000$17000$46000$48000$20000$6000$20000$19000
Stock-based Compensation$1.7M$5.3M0$118000$699000$662000$854000$222000$538000$411000
Variation du BFR$1.9M$1.1M-$778000$744000$809000-$584000-$1.2M$4.4M$2.6M-$2.9M
Cash Flow Opérationnel-$11.0M-$26.9M-$14.5M-$7.0M-$10.8M-$15.1M-$11.7M-$10.8M-$24.7M-$15.7M
CapEx00-$3000-$214000-$4000-$30000-$50000-$8000-$2000
Acquisitions000$1.5M$18000000000
Rachat d'Actions0000000000
Dividendes Payés0000000000
Free Cash Flow-$11.0M-$26.9M-$14.5M-$7.3M-$10.8M-$15.1M-$11.7M-$10.8M-$24.7M-$15.7M

Tableau de Flux (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Cash Flow Opérationnel-$3.0M-$4.9M-$4.3M-$3.8M
CapEx0000
Free Cash Flow-$3.0M-$4.9M-$4.3M-$3.8M
Dividendes Payés0000
Stock-based Compensation$97000$71000$100000$130000

Croissance et Marges (10 ans)

Année2016201720182019202020212022202320242025
Croissance Résultat Net (annuelle)-129.1%+53.5%-37.2%-39.3%+48.5%+8.6%+10.7%-121.3%+53.0%
Croissance BPA (annuelle)-100.3%+47.1%+90.5%+55.1%+63.9%+72.6%+94.3%-44.7%+81.2%
Variation Actions (annuelle)+12.1%+33.1%+846.9%+210.4%+42.7%+233.6%+1476.3%+53.0%+150.4%
Croissance FCF (annuelle)-143.6%+46.3%+49.8%-48.5%-40.6%+22.6%+7.4%-127.8%+36.5%
Taux d'Imposition Effectif-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%

Données par Action (10 ans)

Année2016201720182019202020212022202320242025
FCF par Action$-78878.57$-171343.95$-69157.89$-3664.98$-1752.89$-1726.59$-400.47$-23.53$-35.05$-8.89
Dividende par Action$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Actions en Circulation (Basiques)$140$157$209$1979$6143$8767$29246$461009$705193$1.8M

Quoi regarder en Biotech

La plupart des petites biotechs perdent de l'argent. Les analyser avec le P/E n'a aucun sens — regardez cash et pipeline.

Rentabilité

Marge brute0.00%
Marge opérationnelle0.00%
Marge nette0.00%

Santé financière

Dette / Capitaux propres0.03
Ratio de liquidité2.06

Ratios Clés (10 ans)

Année2016201720182019202020212022202320242025
PER-0.00-0.00-0.00-0.00-0.01-0.02-0.06-1.03-0.57-1.15
P/B0.000.00-0.000.000.020.020.040.771.992.79
P/V0.000.000.000.000.000.000.000.000.000.00
Marge Brute0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Marge Opérationnelle0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Marge Nette0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Entreprises liées: CASI · CLGN · CLSD · ENLV · KLTO · LSTA · NCNA

Explorer le secteur: Healthcare · Biotechnology

Plus de sections de MTVA: Vue d'ensemble · Valorisation · Statistiques · Estimations · Technique · Actionnariat · Actualités · Événements

Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions